TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation.

TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation.
复制标题

DOI:
10.1038/s41598-017-15871-y
复制
发表时间:
2017-11-14
期刊:
影响因子:
4.6
通讯作者:
Hata R
Hata R
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Yahata N;Matsumoto Y;Omi M;Yamamoto N;Hata R

文献摘要

参考文献

被引文献

相似文献

诱导多能干细胞 (iPSC) 适用于研究由线粒体 DNA (mtDNA) 突变引起的线粒体疾病。在这里,我们从一名患有线粒体肌病、脑病、乳酸性酸中毒和中风样发作 (MELAS) 且具有 m.13513G>A 突变的患者中生成了 iPSC。对患者的真皮成纤维细胞进行了重新编程,我们建立了两个带有和不带有突变 mtDNA 的 iPSC 克隆。此外,我们尝试使用转录激活因子样效应核酸酶 (TALEN) 降低 iPSC 中突变 mtDNA 的水平。我们最初设计了铂TALEN,将其转运到线粒体中,识别包括m.13513位置的mtDNA序列,并优先切割G13513A突变体mtDNA(G13513A-mpTALEN)。通过转导 G13513A-mpTALEN,MELAS-iPSC 中的 m.13513G>A 异质性水平在短期内降低。我们的数据表明,这种靶向 mtDNA 的核酸酶将成为改变异质 iPSC 异质性水平的有力工具,这可能有助于阐明 mtDNA 突变引起的线粒体疾病的病理机制。
Induced pluripotent stem cells (iPSCs) are suitable for studying mitochondrial diseases caused by mitochondrial DNA (mtDNA) mutations. Here, we generated iPSCs from a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) with the m.13513G>A mutation. The patient’s dermal fibroblasts were reprogrammed, and we established two iPSC clones with and without mutant mtDNA. Furthermore, we tried to decrease mutant mtDNA level in iPSCs using transcription activator-like effector nucleases (TALENs). We originally engineered platinum TALENs, which were transported into mitochondria, recognized the mtDNA sequence including the m.13513 position, and preferentially cleaved G13513A mutant mtDNA (G13513A-mpTALEN). The m.13513G>A heteroplasmy level in MELAS-iPSCs was decreased in the short term by transduction of G13513A-mpTALEN. Our data demonstrate that this mtDNA-targeted nuclease would be a powerful tool for changing the heteroplasmy level in heteroplasmic iPSCs, which could contribute to elucidation of the pathological mechanisms of mitochondrial diseases caused by mtDNA mutations.
DOI: 10.1093/hmg/ddi184
发表时间: 2005-07-01
影响因子: 3.5
作者:
Hance, N;Ekstrand, MI;Trifunovic, A
通讯作者: Trifunovic, A
DOI: 10.1038/srep03379
发表时间: 2013-11-29
期刊: SCIENTIFIC REPORTS
影响因子: 4.6
作者:
Sakuma, Tetsushi;Ochiai, Hiroshi;Kaneko, Takehito;Mashimo, Tomoji;Tokumasu, Daisuke;Sakane, Yuto;Suzuki, Ken-ichi;Miyamoto, Tatsuo;Sakamoto, Naoaki;Matsuura, Shinya;Yamamoto, Takashi
通讯作者: Yamamoto, Takashi
DOI: 10.1038/mt.2015.126
发表时间: 2015-10-01
期刊: MOLECULAR THERAPY
影响因子: 12.4
作者:
Hashimoto, Masami;Bacman, Sandra R.;Moraes, Carlos T.
通讯作者: Moraes, Carlos T.
DOI: 10.1001/archneurol.2007.67
发表时间: 2008-03-01
影响因子: --
作者:
Shanske, Sara;Coku, Jorida;DiMauro, Salvatore
通讯作者: DiMauro, Salvatore
DOI: 10.1016/j.fob.2015.03.008
发表时间: 2015
期刊: FEBS OPEN BIO
影响因子: 2.6
作者:
Kodaira, Masaki;Hatakeyama, Hideyuki;Yuasa, Shinsuke;Seki, Tomohisa;Egashira, Toru;Tohyama, Shugo;Kuroda, Yusuke;Tanaka, Atsushi;Okata, Shinichiro;Hashimoto, Hisayuki;Kusumoto, Dai;Kunitomi, Akira;Takei, Makoto;Kashimura, Shin;Suzuki, Tomoyuki;Yozu, Gakuto;Shimojima, Masaya;Motoda, Chikaaki;Hayashiji, Nozomi;Saito, Yuki;Goto, Yu-ichi;Fukuda, Keiichi
通讯作者: Fukuda, Keiichi